Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

154.70
Delayed Data
As of 3:59pm ET
 +1.79 / +1.17%
Today’s Change
71.46
Today|||52-Week Range
167.86
+109.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues413.8M458.7M714.7M544.1M
 
 
 
 
 
Cost of Goods Sold39.5M45.0M32.1M56.3M
 
 
 
 
 
Depreciation And Amortization14.6M15.5M14.9M14.9M
 
 
 
 
 
 
Operating ExpensesGross Income359.7M398.2M667.7M472.9M
 
 
 
 
 
General Expenses378.4M358.4M386.9M416.7M
 
 
 
 
 
Research And Development272.4M248.5M273.6M289.5M
 
 
 
 
 
Total Operating Expenses432.5M418.8M433.9M487.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.7M39.9M280.8M56.2M
 
 
 
 
 
Extraordinary Charge-8.0K-224.0K-10.0M-3.5M
 
 
 
 
 
Interest Expense On Debt20.1M20.4M16.8M14.7M
 
 
 
 
 
Other Expenses-167.0K1.1M-544.0K-2.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.0M20.3M253.5M35.5M
 
 
 
 
 
Income Taxes-503.0K-7.5M-4.0M-4.3M
 
 
 
 
 
Minority Interest-696.0K-5.2M-1.8M-13.2M
 
 
 
 
 
Net Income-38.8M32.9M247.4M18.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS244.9M245.5M246.0M247.5M
 
 
 
 
 
Shares To Calculate EPS Diluted244.9M247.8M248.7M251.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16$0.13$0.99$0.07
 
 
 
 
 
EPS Diluted-$0.16$0.13$0.99$0.07